Research ArticleClinical Investigation
Reproducibility of Metabolic Measurements in Malignant Tumors Using FDG PET
Wolfgang A. Weber, Sibylle I. Ziegler, Ralf Thödtmann, Axel-R. Hanauske and Markus Schwaiger
Journal of Nuclear Medicine November 1999, 40 (11) 1771-1777;
Wolfgang A. Weber
Sibylle I. Ziegler
Ralf Thödtmann
Axel-R. Hanauske
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Reproducibility of Metabolic Measurements in Malignant Tumors Using FDG PET
Wolfgang A. Weber, Sibylle I. Ziegler, Ralf Thödtmann, Axel-R. Hanauske, Markus Schwaiger
Journal of Nuclear Medicine Nov 1999, 40 (11) 1771-1777;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
- Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
- Repeatability of SUV in Oncologic 18F-FDG PET
- Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
- Multicenter Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors
- Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas
- Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
- 18F-FLT PET Evaluation of Radiation Response
- Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test-Retest Measurements for Tumor FDG Uptake, Diameter, and Volume
- Variability of Total Lesion Glycolysis by 18F-FDG-Positive Tissue Thresholding in Lung Cancer
- Using FDG-PET to Measure Early Treatment Response in Head and Neck Squamous Cell Carcinoma: Quantifying Intrinsic Variability in Order to Understand Treatment-Induced Change
- 18F-FDG Uptake by Metastatic Axillary Lymph Nodes on Pretreatment PET/CT as a Prognostic Factor for Recurrence in Patients with Invasive Ductal Breast Cancer
- Noise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake Value
- Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis
- Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET
- Coronary Arterial 18F-Sodium Fluoride Uptake: A Novel Marker of Plaque Biology
- Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients With Aortic Stenosis
- Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer
- Predictive Value of Initial 18F-FLT Uptake in Patients with Aggressive Non-Hodgkin Lymphoma Receiving R-CHOP Treatment
- Quantifying and Reducing the Effect of Calibration Error on Variability of PET/CT Standardized Uptake Value Measurements
- Standardization of Quantitative Imaging: The Time Is Right, and 18F-FDG PET/CT Is a Good Place to Start
- Phenotyping of Tumor Biology in Patients by Multimodality Multiparametric Imaging: Relationship of Microcirculation, {alpha}v{beta}3 Expression, and Glucose Metabolism
- Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation
- The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lecture
- Reproducibility of 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine PET Tumor Volume Measurements
- Reproducibility of [11C]Choline-Positron Emission Tomography and Effect of Trastuzumab
- Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
- Assessment of Interobserver Reproducibility in Quantitative 18F-FDG PET and CT Measurements of Tumor Response to Therapy
- Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies
- Imaging of Proliferation in Hepatocellular Carcinoma with the In Vivo Marker 18F-Fluorothymidine
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- Role of 18F-FDG PET in Assessment of Response in Non-Small Cell Lung Cancer
- Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
- Response to Therapy in Breast Cancer
- Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data
- Measuring Response with FDG-PET: Methodological Aspects
- Imaging Surrogates of Tumor Response to Therapy: Anatomic and Functional Biomarkers
- Comparison of Methods for Magnetic Resonance-Guided [18-F]Fluorodeoxyglucose Positron Emission Tomography in Human Carotid Arteries: Reproducibility, Partial Volume Correction, and Correlation Between Methods
- Reproducibility of Standardized Uptake Value Measurements Determined by 18F-FDG PET in Malignant Tumors
- In Vivo Characterization of Proliferation for Discriminating Cancer from Pancreatic Pseudotumors
- Analysis and Reproducibility of 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer
- Detection of Neovessels in Atherosclerotic Plaques of Rabbits Using Dynamic Contrast Enhanced MRI and 18F-FDG PET
- Treatment Monitoring by 18F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors
- Use of H215O-PET and DCE-MRI to Measure Tumor Blood Flow
- Long-Term Precision of 18F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism
- Application of PET/CT in the Development of Novel Anticancer Drugs
- Imaging Gastric Cancer with PET and the Radiotracers 18F-FLT and 18F-FDG: A Comparative Analysis
- [18F]Galacto-RGD Positron Emission Tomography for Imaging of {alpha}v{beta}3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head and Neck
- 18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?
- Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pilot Study
- 18Fluorodeoxyglucose Positron Emission Tomography Imaging of Atherosclerotic Plaque Inflammation Is Highly Reproducible: Implications for Atherosclerosis Therapy Trials
- Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma
- Early Response Assessment Using 3'-Deoxy-3'-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma
- Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF
- Partial-Volume Effect in PET Tumor Imaging
- Deep-Inspiration Breath-Hold PET/CT: Clinical Findings with a New Technique for Detection and Characterization of Thoracic Lesions
- Reproducibility of 18F-FDG microPET Studies in Mouse Tumor Xenografts
- Monitoring Cancer Treatment with PET/CT: Does It Make a Difference?
- Monitoring targeted therapy: is fluorodeoxylucose uptake a marker of early response?
- The Role of PET in Lymphoma
- High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
- Positron Emission Tomography As an Imaging Biomarker
- Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin {alpha}v{beta}3 Expression in Man.
- Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials
- Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non-Small-Cell Lung Cancer
- Reproducibility of 3'-Deoxy-3'-18F-Fluorothymidine MicroPET Studies in Tumor Xenografts in Mice
- PET for response assessment in oncology: radiotherapy and chemotherapy
- Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
- Early Prediction of Response to Chemotherapy in Metastatic Breast Cancer Using Sequential 18F-FDG PET
- 2-[11C]Thymidine Positron Emission Tomography Reproducibility in Humans
- Use of PET for Monitoring Cancer Therapy and for Predicting Outcome
- Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
- Application of Intravenous Contrast in PET/CT: Does It Really Introduce Significant Attenuation Correction Error?
- Comparison of Different Quantitative Approaches to 18F-Fluoride PET Scans
- Effects of Noise, Image Resolution, and ROI Definition on the Accuracy of Standard Uptake Values: A Simulation Study
- Simplified Kinetic Analysis of Tumor 18F-FDG Uptake: A Dynamic Approach
- Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment
- Respiratory Gating for 3-Dimensional PET of the Thorax: Feasibility and Initial Results
- Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
- Positron Emission Tomography in Non-Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use
- Cause and Magnitude of the Error Induced by Oral CT Contrast Agent in CT-Based Attenuation Correction of PET Emission Studies
- Functional imaging for assessment of therapy
- Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging
- The Diagnostic Utility of the Lognormal Behavior of PET Standardized Uptake Values in Tumors